Review
Accepted on 26 Nov 2025
Dysfunctional High-Density Lipoprotein: An Updated Review
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
- 140 views
Type at least 3 characters
273 articles
Correction
Published on 26 Nov 2025
Correction: lipid and immunophenotypic profiles in hemodialysis patients with citrate vs. acetate dialysates
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2025.1744975
- 223 views
Original Research
Published on 17 Nov 2025
The relationship between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and abdominal aortic calcification in adults: a cross-sectional study
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2025.1578407
- 528 views
Review
Published on 29 Oct 2025
From meal to malfunction: exploring molecular pathways, biomarkers and interventions in postprandial cardiometabolic health
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2025.1655889
- 1,450 views
Systematic Review
Published on 29 Oct 2025
Effectiveness of combining PCSK9 inhibitors with statins on major adverse cardiovascular events and lipid levels in patients after percutaneous coronary intervention: a systematic review and meta-analysis
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2025.1612095
- 1,504 views
Review
Published on 24 Oct 2025
LDL atherogenicity determined by size, density, oxidation, apolipoprotein(a), and electronegativity: an updated review
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2025.1649759
- 1,838 views
Case Report
Published on 20 Oct 2025
Case Report: Beating the assumed prognosis: homozygous familial hypercholesterolemia with unexpected long survival
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2025.1643771
- 784 views
Original Research
Published on 03 Oct 2025
Remnant cholesterol, not LDL cholesterol, is associated with the risk of hypertension in the middle-aged and elderly population: Bushehr Elderly Health cohort
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2025.1483778
- 1,116 views
Case Report
Published on 22 Sep 2025
PCSK9 inhibitor failure in a statin-intolerant FH patient with a novel LDLR variant: a case report
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2025.1644145
- 1,955 views
Original Research
Published on 15 Sep 2025
Composition of cardiac-derived extracellular vesicles changes with vesicle origin and determines uptake
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2025.1565104
- 2,086 views
Original Research
Published on 05 Sep 2025
Suboptimal management of hypercholesterolemia in countries with high or very high cardiovascular risk: findings from the international DISCOVERY study
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2025.1665059
- 2,189 views
Original Research
Published on 22 Aug 2025
Patterns and characteristics of dyslipidemia subtypes among community-dwelling elderly in Eastern China: a cross-sectional study
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2025.1634134
- 1,532 views
Original Research
Published on 14 Jul 2025
Association between fasting glucose/high-density lipoprotein cholesterol ratio and cardiovascular disease risk in Chinese middle-aged and older adults: a longitudinal study
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2025.1609891
- 2,613 views
Mini Review
Published on 10 Jul 2025
Reverse cholesterol transport: current assay methods, alterations with disease and response to therapeutic intervention
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2025.1608384
- 2,932 views
Original Research
Published on 08 Jul 2025
Lipoprotein(a) as an early marker of cardiovascular events in high-risk subjects: insights from the Moli-sani cohort study
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2025.1571395
- 2,981 views
Opinion
Published on 01 Jul 2025
Elevated levels of lipoprotein(a) and low-density lipoprotein cholesterol in familial hypercholesterolemia patients: is dual primary prevention already in sight?
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2025.1624049
- 2,525 views
- 1 citation